Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
307.4 USD | +0.51% | +0.52% | +6.74% |
05-28 | US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment | RE |
05-28 | Amgen's Rare-Disease Treatment Biosimilar Bkemv Gets FDA Approval | DJ |
ETFs positioned on Amgen Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.84% | 0 M€ | 0.00% | - | |
7.63% | 0 M€ | 0.00% | - | |
5.08% | 116 M€ | +15.14% | - | |
3.71% | 17 M€ | +7.32% | - | |
3.24% | 1 M€ | 0.00% | - | |
2.61% | 1 M€ | +2.21% | - | |
2.06% | 2 M€ | -.--% | - | |
1.75% | 4,592 M€ | -.--% | ||
1.73% | 9 M€ | -4.31% | - | |
1.67% | 9 M€ | -.--% | - | |
1.65% | 8 M€ | -.--% | ||
1.55% | 800 M€ | +4.84% | ||
1.37% | 2 M€ | +20.44% | - | |
1.31% | 5 M€ | -72.95% | - | |
1.29% | 3 M€ | 0.00% | - | |
1.19% | 15 M€ | 0.00% | - | |
1.04% | 3,859 M€ | +18.82% | - | |
1.04% | 469 M€ | -2.05% | ||
1.04% | 1,100 M€ | +2.41% | ||
0.88% | 2 M€ | 0.00% | ||
0.77% | 265 M€ | +3.72% | - | |
0.75% | 7 M€ | +0.11% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.74% | 164B | |
+42.60% | 739B | |
+32.34% | 598B | |
-5.74% | 353B | |
+17.79% | 318B | |
+3.37% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+1.81% | 162B |
- Stock Market
- Equities
- AMGN Stock
- Funds and ETFs Amgen Inc.